Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | NAMZARIC® | For Healthcare Professionals |
Description | GIVe them an opportunity for improved cognition and global Learn about NAMZARIC (memantine HCL & donepezil HCl) extended-release capsules for the treatment of moderate AD – See Important Safety |
Keywords | N/A |
WebSite | namzarichcp.com |
Host IP | 72.52.10.14 |
Location | United States |
Site | Rank |
US$3,185,384
Last updated: 2023-05-13 17:44:51
namzarichcp.com has Semrush global rank of 3,322,772. namzarichcp.com has an estimated worth of US$ 3,185,384, based on its estimated Ads revenue. namzarichcp.com receives approximately 367,545 unique visitors each day. Its web server is located in United States, with IP address 72.52.10.14. According to SiteAdvisor, namzarichcp.com is safe to visit. |
Purchase/Sale Value | US$3,185,384 |
Daily Ads Revenue | US$2,941 |
Monthly Ads Revenue | US$88,211 |
Yearly Ads Revenue | US$1,058,528 |
Daily Unique Visitors | 24,503 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
namzarichcp.com. | A | 300 | IP: 72.52.10.14 |
namzarichcp.com. | NS | 86400 | NS Record: ha2.markmonitor.zone. |
namzarichcp.com. | NS | 86400 | NS Record: ha4.markmonitor.zone. |
namzarichcp.com. | NS | 86400 | NS Record: ha1.markmonitor.zone. |
namzarichcp.com. | NS | 86400 | NS Record: ha3.markmonitor.zone. |
namzarichcp.com. | MX | 14400 | MX Record: 10 mxb-0015e701.gslb.pphosted.com. |
namzarichcp.com. | MX | 14400 | MX Record: 10 mxa-0015e701.gslb.pphosted.com. |
namzarichcp.com. | TXT | 3600 | TXT Record: de34ad0c2b8a429798fd8b5cfd9fed97 |
namzarichcp.com. | TXT | 3600 | TXT Record: v=spf1 mx include:spf-0015e701.pphosted.com ~all |
CLOSE HOME About NAMZARIC MOA EFFICACY SAFETY PROFILE DOSING PATIENT IDENTIFICATION MODERATE STAGE AD FORMULARY COVERAGE RESOURCES NAMZARIC TRIAL OFFER Important Safety Information Full Prescribing Information Caregiver Site Request Samples NAMZARIC Trial Offer Important Safety Information Full Prescribing Information Caregiver Site Request Samples Important Safety Information Full Prescribing Information Menu For your moderate Alzheimer’s disease (AD) patients stabilized on donepezil HCI 10 mg, GIVe them an opportunity for improved cognition and global function Treat your appropriate moderate to severe AD patients proactively with NAMZARIC ® . Efficacy RESULTS STARTING NAMZARIC In a clinical trial of 677 patients with moderate to severe AD on stable AChEI* therapy, adding NAMENDA XR ® (memantine HCl) extended-release capsules 28 mg was statistically significantly superior to placebo+AChEI at 24 weeks (using an LOCF † analysis) in the co-primary endpoints of cognition, as measured by |
HTTP/1.1 301 Moved Permanently cache-control: no-cache, no-store, must-revalidate Pragma: no-cache Expires: -1 X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff X-Frame-Options: DENY Content-Security-Policy: script-src 'self' Location: http://www.namzarichcp.com/ Vary: Accept Content-Type: text/plain; charset=utf-8 Content-Length: 61 Date: Tue, 21 Dec 2021 20:43:37 GMT Connection: keep-alive Set-Cookie: NSC_us_nbsl-83+63+21+25-91=ffffffff2fe62ef045525d5f4f58455e445a4a423660;path=/;httponly HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Tue, 21 Dec 2021 20:43:37 GMT Content-Type: text/html Content-Length: 183 Connection: keep-alive Location: https://www.namzarichcp.com/ X-Cache: Redirect from cloudfront Via: 1.1 a6cca18455d155ffa87e5da1963e8d88.cloudfront.net (CloudFront) X-Amz-Cf-Pop: EWR53-C3 X-Amz-Cf-Id: gp_O8TGLfJnUm7nR7TAtsn-RMjPSOh0V0smADfEXWf4Gym_fW3bT_Q== HTTP/1.1 200 OK Content-Type: text/html; charset=utf-8 Content-Length: 60894 Connection: keep-alive Date: Tue, 21 Dec 2021 20:41:43 GMT Cache-Control: private X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET Strict-Transport-Security: max-age=31536000 Server: Microsoft-IIS/8.5 Vary: Accept-Encoding X-Cache: Miss from cloudfront Via: 1.1 f800b68f44c427976fe7546b255b6206.cloudfront.net (CloudFront) X-Amz-Cf-Pop: JFK51-C1 X-Amz-Cf-Id: NEPHwo-SJpS4Anhi6_Ed8QiQGc3D3S5OpMXmT55LkSIn9-qAnSFjgg== |
Domain Name: NAMZARICHCP.COM Registry Domain ID: 1891759764_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-03-10T01:32:38Z Creation Date: 2014-12-22T16:35:33Z Registry Expiry Date: 2022-12-22T16:35:33Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: HA1.MARKMONITOR.ZONE Name Server: HA2.MARKMONITOR.ZONE Name Server: HA3.MARKMONITOR.ZONE Name Server: HA4.MARKMONITOR.ZONE DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T08:16:07Z <<< |